Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid

Archives of Dermatological Research

Volumn 305, Issue 3, 2013, Pages 255-262

  Balato, Anna ^a   Schiattarella, Maria ^a   Lembo, Serena ^a   Mattii, Martina ^a   Prevete, Nella ^a   Balato, Nicola ^a   Ayala, Fabio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Immune regulation; Inflammation; Interleukin 1 family; Psoriasis; Retinoic acid; Vitamin D

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 36 RECEPTOR ANTAGONIST; INTERLEUKIN 36ALPHA; INTERLEUKIN 36BETA; INTERLEUKIN 36GAMMA; MESSENGER RNA; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; SKIN CULTURE; ULTRAVIOLET RADIATION;

BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-17; KERATINOCYTES; KERATOLYTIC AGENTS; ORGAN CULTURE TECHNIQUES; PSORIASIS; RNA, MESSENGER; SKIN; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS; VITAMIN D;

EID: 84876462567     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1327-8     Document Type: Article

References (32)

1. Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A, Balato N, Ayala F (2012) IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 21:892-894
2. Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, Peschon JJ (2007) Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204:2603-2614
3. Bollag W (1983) Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1(8329):860-863
4. Buck J, Ritter G, Dannecker L, Katta V, Cohen SL, Chait BT, Hämmerling U (1990) Retinol is essential for growth of activated human B cells. J Exp Med 171:1613-1624
5. Byrne SN, Beaugie C, O'Sullivan C, Leighton S, Halliday GM (2011) The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am J Pathol 179:211-222
6. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG (2011) Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 131:2428-2437
7. Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S, Krueger JG (2011) Integrative responses to IL-17 and TNF-a in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131:677-687
8. Cowen EW, Goldbach-Mansky R (2012) DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? Arch Dermatol 148:381-384
9. Debets R, Timans JC, Homey B, Zurawski S, Sana TR, Lo S, Wagner J, Edwards G, Clifford T, Menon S, Bazan JF, Kastelein RA (2001) Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol 167:1440-1446
10. Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, Gabel C (2010) IL-1 family nomenclature. Nat Immunol 11:973
11. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, O'Shea JJ (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111:1013-1020
12. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, Cavani A, Mempel M, Traidl-Hoffmann C, Eyerich K (2011) IL-22 and TNF-a represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 41:1894-1901
13. Gross V, Villiger PM, Zhang B, Lotz M (1993) Retinoic acid inhibits interleukin-1-induced cytokine synthesis in human monocytes. J Leukoc Biol 54:125-132
14. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40:23-25
15. Ikeda U, Wakita D, Ohkuria T, Chamoto K, Kitamura H, Iwakura Y, Nishimura T (2010) 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 134:7-16
16. Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE (2011) IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186:2613-2622
17. Kong J, Grando SA, Li YC (2006) Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes. J Immunol 176:3780-3787
18. Kunisch E, Chakilam S, Gandesiri M, Kinne RW (2012) IL-33 regulates TNF-α dependent effects in synovial fibroblasts. Int J Mol Med 29:530-540
19. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schröder JM, Liu YJ, Gilliet M (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564-569
20. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-873
21. Muhr P, Zeitvogel J, Heitland I, Werfel T, Wittmann M (2011) Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors. Br J Dermatol 165:189-193
22. Nestle FO, Conrad C (2004) Mechanisms of psoriasis. Drug Discov Today 1:315-319
23. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014-1022
24. Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Büchau A, Steinmeyer A, Zügel U, Ruzicka T, Schauber J (2009) Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One 4:e6340
25. Schauber J, Gallo RL (2008) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 122:261-266
26. Sharma S, Kulk N, Nold MF, Gräf R, Kim SH, Reinhardt D, Dinarello CA, Bufler P (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477-5482
27. Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89-102
28. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE (2008) IL-33 amplifies both Th1- and Th2-type responses through it activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019-1030
29. Theoharides TC, Zhang B, Kempuraj D (2010) IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 107(9):4448-4453
30. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE (2004) Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 279:13677-13688
31. Trémezaygues L, Reichrath J (2011) Vitamin D analogs in the treatment of psoriasis. Where are we standing and where will we be going? Dermatoendocrinology 3(3):180-186
32. Van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, Netea MG, Joosten LA, van der Meer JW, Hao R, Kalabokis V, Dinarello CA (2012) IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA 109:3001-3005